Top compounds associated with response to IRF7


Feature Type Standardized
Nominal ANOVA
mRNA CUDC-101 GDSC1000 pan-cancer AAC 0.03 0.4
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA AZD0530 FIMM pan-cancer AAC 0.15 0.4
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.033 0.4
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.4
mRNA IOX2 GDSC1000 pan-cancer AAC -0.032 0.4
mRNA AP-24534 FIMM pan-cancer AAC -0.16 0.4
mRNA SGX-523 CTRPv2 pan-cancer AAC -0.034 0.4
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.4
mRNA linifanib GDSC1000 pan-cancer AAC -0.033 0.4
Download CSV